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Breast cancer cell linesTriterpenoids are a large class of naturally occurring compounds, and some potentially interesting as
anticancer agents have been found to target mitochondria. The objective of the present work was to
investigate the mechanisms of mitochondrial toxicity induced by novel dimethylaminopyridine (DMAP)
derivatives of pentacyclic triterpenes, which were previously shown to inhibit the growth of melanoma
cells in vitro. MCF-7, Hs 578T and BJ cell lines, as well as isolated hepatic mitochondria, were used to
investigate direct mitochondrial effects. On isolated mitochondrial hepatic fractions, respiratory param-
eters, mitochondrial transmembrane electric potential, induction of the mitochondrial permeability tran-
sition (MPT) pore and ion transport-dependent osmotic swelling were measured. Our results indicate
that the DMAP triterpenoid derivatives lead to fragmentation and depolarization of the mitochondrial
network in situ, and to inhibition of uncoupled respiration, induction of the permeability transition pore
and depolarization of isolated hepatic mitochondria. The results show that mitochondrial toxicity is an
important component of the biological interaction of DMAP derivatives, which can explain the effects
observed in cancer cells.
 2013 Elsevier Ltd. All rights reserved.1. Introduction includes antiviral,1 antifungal, anti-inflammatory2 and antitumorTriterpenoids are naturally occurring compounds with ubiqui-
tous distribution, and whose biological activity in mammalian cellseffects.3–5
Several triterpenoids appear to exert their effects via disruption
of mitochondrial function, namely by inducing the generation of
reactive oxygen species, disruption of redox status, calcium
deregulation, decrease in mitochondrial potential and cytochrome
c release.6,7 These deleterious effects onmitochondriamay be inter-
esting from a chemotherapeutic perspective, as they could be of use
in promoting apoptosis inmalignant cells. For example, the triterpe-
noidbetulinic acid selectivelypromotes apoptosis ofmelanomacan-
cer cells,8 and also exhibits cytotoxic activity in glioma, ovarian
carcinoma and cervical carcinoma cell lines.5 However, the use of
triterpenoids remains quite limited due to their low solubility, high
pH in solution and high molecular weight,9 evidencing the need of
new synthetic derivatives that may overcome these limitations.
Our research group has previously shown that a number of
dimethylaminopyridine (DMAP) derivatives of lupane triterpe-
noids inhibited human melanoma cell proliferation and the extent
of proliferation inhibition was correlated with the strength of
mitochondrial depolarization.5 However, the mechanisms behind
the mitochondrial effects were not completely elucidated.
Here, we investigate in detail the effects of the same com-
pounds on isolated hepatic mitochondrial fractions, including
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(MPTP), in order to explain the mitochondrial alterations observed
in melanoma5 and breast cancer cells (this work).
2. Materials and methods
2.1. General chemicals
MitoTracker Red CMXRos was obtained from Molecular Probes
(Invitrogen, Eugene, OR, USA); Sulforhodamine B (SRB) was
obtained from Sigma (St Louis, MO, USA). All other reagents and
chemical compounds used were of the greatest degree of purity
commercially available. In the preparation of every solution, ultra-
pure distilled water, filtered by the Milli Q from a Millipore system,
was always used in order tominimize the contaminationwithmetal
ions.
2.2. Synthesis and preparation of the compounds
Birch bark lupane triterpenoids betulin and betulinic acid
have been chosen as basic natural precursors for synthesis of
DMAP derivatives of the pentacyclic triterpenes: 28-(40-dimethyl-
aminopyridinium-10-acetoxy)-3b-hydroxylup-20(29)-ene chloride
(1); betulin 30-[40-(dimethylamino)pyridinium-10-yl]-3b,28-di[40-
(dimethylamino)pyridinium-1-yl acetoxy)] tribromide (2); lup-
20-(29)-ene-3b-(40-dimethylaminopyridiniumacetoxy)chloride
(3); betulin 3b,28-di[(40-dimethylaminopyridinium-10-yl)acetoxy]
bromide (4) and betulinic acid 28-(40-dimethylaminopyridini-
um-10-yl) bromide (5) (Fig. 1), which correspond, respectively,
to compounds 7, 5, 10, 14 and 1 in our previous study.5 Betulin
with 99% purity was isolated from the extract of outer birch bark
of Betula papyrifera—the North American commercial birch tree—
and betulinic acid was then synthesized from betulin. The com-
pounds were prepared as stock solutions in dimethylsulfoxide
(DMSO), as described previously.5Figure 1. DMAP compounds synthesized from betulin and betulinic acid. (1) 28-(40-Dim
30-[40-(dimethylamino)pyridinium-10-yl]-3b,28-di[40-(dimethylamino)pyridinium-1-yl-a
chloride; (4) betulin 3b,28-di[(40-dimethylaminopyridinium-10-yl)acetoxy] bromide; (5
betulinic acid is highlighted in bold.2.3. Composition of solutions
Phosphate buffered saline solution (PBS): 132.0 mM NaCl,
4.0 mM KCl; 1.2 mM NaH2PO4. PBS Tween (PBST): PBS with 0.1%
Tween 20. Trypan blue was used as a 0.04% (w/v) solution in PBS.2.4. Animal handling
Eight-10 week male Wistar–Han rats were housed in our
accredited animal colony (Laboratory Research Center, Faculty of
Medicine, University of Coimbra, Portugal) in type III-H cages (Tec-
niplast, Italy) and maintained in specific environmental require-
ments: 22 C, 45–65% humidity, 15–20 changes/h ventilation,
12 h artificial light/dark cycle, noise level <55 dB. Rats had free ac-
cess to standard rodent food (4RF21 GLP certificate, Mucedola,
Italy) and water (acidified at pH 2.6 with HCl to avoid bacterial
contamination). This research procedure was carried out in accor-
dance with European Requirements for Vertebrate Animal Re-
search and according to the ethical standards for animal
manipulation at the Center for Neuroscience and Cell Biology.2.5. Cell culture
MCF-7 (HTB-22, ECACC, United Kingdom) and Hs 578T (HTB-
125, ATCC, Manassas, VA, USA), breast cancer cell lines, as well as
normal BJ fibroblasts (CRL-2522, ATCC, Manassas, VA, USA), were
cultured in monolayers in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 1.8 g/l sodium bicarbonate, 10% fetal
bovine serum, and 1% of penicillin–streptomycin, in 75 cm2 tissue
culture flasks at 37 C in a humidified atmosphere of 5% CO2. Cells
were fed every 2–3 days, and sub-cultured once they reached 70–
80% of confluence. BJ fibroblasts were used between passage 10
and 25.ethylaminopyridinium-10-acetoxy)-3b-hydroxylup-20(29)-ene chloride; (2) betulin
cetoxy)] tribromide; (3) lup-20-(29)-ene-3b-(40-dimethylaminopyridiniumacetoxy)
) betulinic acid 28-(40-dimethylaminopyridinium-10-yl) bromide. The structure of
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For detection of morphological alterations including chromatin
condensation and polarized mitochondrial network morphology,
cells were seeded in six-well plates containing glass coverslips (fi-
nal volume of 2 ml/well at the same density described in for cell
proliferation studies) and allowed to attach for 24 h. The human
breast cancer cell lines and the normal fibroblast line were then
treated with the test compounds for 48 h. Thirty minutes prior
the end of the incubation time, the cultures were incubated with
MitoTracker Red CMXRos (7.3 nM) at 37 C in the dark, washed
with cold PBS, and fixed with ice cold absolute methanol overnight
at 20 C. The cells were then gently rinsed three times with PBST,
for 5 min in the dark, at room temperature. Glass coverslips were
removed from the wells and placed on glass slides with a drop of
mounting medium. The images were obtained using a 63 objec-
tive in a Zeiss Axioskop 2 Plus microscope.
2.7. Isolation of rat hepatic mitochondria
Mitochondria were isolated from the livers of male Wistar rats
by conventional differential centrifugation.10 Rats were killed by
decapitation and the livers were harvested, minced and washed
in ice-cold buffer medium containing 250 mM sucrose, 10 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH
7.2), 1 mM EGTA, and 0.1% lipid-free bovine serum albumin
(BSA). Tissue fragments were quickly homogenized with a motor-
driven Teflon Potter homogenizer in the presence of ice-cold isola-
tion medium (7 g/50 ml). Hepatic homogenate was centrifuged at
800g for 10 min (Sorvall RC6 centrifuge) at 4 C and mitochondria
were recovered from the supernatant by centrifugation at 10,000g
for 10 min. The mitochondrial pellet was resuspended using a
paintbrush and centrifuged twice at 10,000g for 10 min before
obtaining a final mitochondrial suspension. EGTA and BSA were
omitted from the final washing medium, which was adjusted to
pH 7.2. Protein content was determined by the biuret method,11
using BSA as a standard.
2.8. Measurement of mitochondrial oxygen consumption
Oxygen consumption of isolated hepatic mitochondria was
polarographically monitored with a Clark-type oxygen electrode
connected to a suitable recorder in a 1 ml temperature-controlled,
water-jacketed, and closed chamber with constant magnetic stir-
ring. The reactions were carried out at 30 C in 1 ml of standard
respiratory mediumwith 1 mg of hepatic mitochondria. Mitochon-
drial respiratory medium comprised 130 mM sucrose, 50 mM KCl,
2.5 mMMgCl2, 5 mM KH2PO4 , 0.1 mM EGTA and 5 mM HEPES (ad-
justed at pH 7.2). The triterpenoid derivative compounds were pre-
incubated with 1 mg mitochondria for 1 min, before adding the
respiratory substrate. This incubation period was carried out to en-
sure the complete mitochondrial accumulation of the compounds
based on their chemical characteristics. The respiratory substrates,
glutamate/malate (10 mM/5 mM) or succinate (5 mM) plus rote-
none (3 lM), were added to the medium to energize mitochondria,
while ADP (187.5 nmol/mg protein) was used to induce state 3 res-
piration. In order to block proton influx through the ATP synthase
under state 4 respiration, 1 lg oligomycin was added to the sys-
tem. To uncouple respiration and measure the maximal electron
transfer rate through the respiratory chain, 1 lM carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP) was added. The respi-
ratory control ratio (RCR) represents a measure of oxidative phos-
phorylation coupling and is calculated as the rate between state 3
and state 4. The ADP/O ratio is indicative of the efficiency of oxida-
tive phosphorylation. Both indexes were determined according toChance andWilliams.12 Respiration rates were calculated consider-
ing an air saturated water oxygen concentration, at 30 C (236 lM).
2.9. Measurement of mitochondrial transmembrane electric
potential (DWm)
The DWm of isolated hepatic mitochondria was monitored indi-
rectly in a 1 ml thermostated, water-jacketed, open chamber with
constant magnetic stirring, using an ion-selective electrode to
measure the distribution of tetraphenylphosphonium (TPP+)
according to previously established methods. The reference elec-
trode was Ag/AgCl2. Mitochondrial protein (1 mg) was suspended
in reaction medium composed of 130 mM sucrose, 50 mM KCl,
2.5 mM MgCl2, 5 mM KH2PO4, 0.1 mM EGTA and 5 mM HEPES
(pH 7.2, 30 C), and supplemented with 3 lM TPP+. Triterpenoid
derivative compounds were added to mitochondria for 1 min, fol-
lowed by 5 mM glutamate/2.5 mM malate or 5 mM succinate plus
3 lM rotenone. In order to initiate state 3 respiration, ADP
(125 nmol/mg protein) was added. Addition of valinomycin
(0.2 lg) at the end of all experiments led to a complete collapse
of DWm and allowed evaluating if test compounds interfered with
the electrode. Assuming a Nernst distribution of the ion across the
membrane electrode, the equation proposed by Kamo et al.13
yielded the values for transmembrane electric potential.
2.10. Effects of the compounds on mitochondrial permeability
transition: evaluation of calcium-induced DWm depolarization
The phenomenon of the mitochondrial permeability transition
(MPT) occurs when a large amount of Ca2+ is accumulated by mito-
chondria in the presence of an inducing agent such as phosphate
(Pi), leading to mitochondrial depolarization caused by the forma-
tion of pores, possibly formed by ATP synthase dimers.14 The DWm
fluctuations associated with the uptake of calcium and the induc-
tion of the MPT pore were followed with a TPP+-selective electrode
(as described above), in an open thermostated water-jacketed
reaction chamber with magnetic stirring, at 30 C. Mitochondria
(1 mg) were suspended in 1 ml of reaction medium consisting of
200 mM sucrose, 10 mM tris-3-(N-morpholino)propanesulfonic
acid (MOPS) (pH 7.2), 10 lM EGTA, 1 mM KH2PO4, 3 lM rotenone,
supplemented with 3 lM TPP+. Mitochondria were incubated with
the test compounds for 1 min, to guarantee their total internaliza-
tion, and then energized with 5 mM succinate. Two pulses of 30–
60 nmol calcium (CaCl2) were added to the reaction medium in
the assays. As a control, mitochondrial preparations were pre-incu-
bated with cyclosporin A (1 lM), a specific MPT pore desensi-
tizer,15 in the presence of the highest concentration of the tested
compounds that induced mitochondrial swelling. As a positive
control, FCCP (25  103 nmol) was incubated with mitochondrial
suspension before calcium addition, in order to induce a small
reduction in DWm.
2.11. Effects of the compounds on MPT: measurement of
calcium-induced mitochondrial swelling
The induction of the MPT pore in isolated mitochondrial frac-
tions leads to mitochondrial swelling, which can be estimated by
changes in light scattering of the hepatic mitochondrial suspen-
sion. The turbidity of the mitochondrial suspension was measured
at 540 nm in a Lambda 45 UV/VIS Spectrometer (Perkin Elmer, Inc.,
Boston, MA, USA). Mitochondrial protein 0.5 mg/ml (final volume
of 2 ml) was incubated for 1 min at 30 C in reaction medium
(see previous section) in the presence of the triterpenoid com-
pounds under study. Mitochondrial swelling was induced by add-
ing CaCl2 to the system. As a control, 1 lM CsA was incubated with
the mitochondrial preparation in the presence of the highest con-
Figure 2. Epifluorescence micrographs showing the effect of DMAP triterpenoid
derivatives on mitochondrial polarization in BJ, MCF-7 and Hs 578T cell lines. Cells
were incubated in the absence or in the presence of the compounds at 1 lg/ml for
48 h. Thirty minutes before the end of incubation period cells were incubated with
MitoTracker Red (7.3 nM). Images were obtained with a Zeiss Axioskop 2 Plus
microscope. The white arrows indicate mitochondrial depolarization and the white
bar represents 20 lm. These results are representative of three independent
experiments.
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swelling. Mitochondrial swelling rates were calculated starting
2 min after calcium addition and measured during 1 min.
2.12. Osmotic swelling experiments
Passive proton and potassium permeability of the mitochon-
drial inner membrane in the presence or absence of the triterpe-
noids derivative compounds was estimated by measuring the
swelling of non-respiring mitochondria in isosmotic media con-
taining NH4NO3, KSCN or KCH3COO. Rat liver mitochondria
(1 mg) were incubated at 25 C in 2 ml ionic medium constituted
by 135 mM of NH4NO3, KSCN or KCH3COO, 10 mM HEPES and
0.1 mM EDTA supplemented with 2 lM rotenone. Valinomycin
(1 lg) was used in order to increase the permeability to potassium,
while FCCP (1 lM) was used to increase permeability to protons.
Triterpenoid compounds were tested for the maximum
concentration used in other experiments (6 lg/mg protein). For
this particular experiment, only compounds that caused MPT pore
induction were tested (i.e., compound (5) was not tested).
Decreases in turbidity were measured at 540 nm in a Lambda 45
UV/VIS Spectrometer (Perkin Elmer, Inc., Boston, MA, USA), in tem-
perature-controlled chambers.
2.13. Statistical analysis
Data was loaded to GraphPad Prism 5.0 software (GraphPad
Software, Inc., San Diego, CA, USA) and all results are expressed
as means ± standard error of the mean (SEM) and evaluated by
one-way ANOVA followed by Bonferroni multiple comparison
tests. Values with p < 0.05 were considered as statistically
significant.
3. Results
3.1. Mitochondrial depolarization caused by DMAP triterpenoid
derivatives on breast cancer lines, and BJ fibroblasts
In order to investigate whether the five DMAP triterpenoid
derivatives previously tested by our group in melanoma cells5 also
depolarize mitochondria in breast cancer cells, the estrogen-sensi-
tive MCF-7 and the estrogen-insensitive Hs 578T breast cancer cell
lines were exposed to 1 lg/ml of each compound, for 48 h, and the
effects were compared with the non-cancer BJ fibroblast cell line,
also used as control in our previous study.5 Thirty minutes prior
to the end of the incubation period, the cells were incubated with
MitoTracker Red (7.3 nM), which is incorporated by polarized
mitochondria in live cells depending on their DWm. The results
show that compound (5) (Fig. 2) did not have any visible effect
on mitochondrial polarization in any of the cell lines in study, for
the concentration and time exposure chosen. In turn, treatment
with compounds (2), (3) and (4) resulted in mitochondrial depolar-
ization for these concentrations in normal BJ fibroblasts and in
both cancer cell lines (Fig. 2) after 48 h of incubation. Thus, all
DMAP triterpenoid derivatives tested, except compound (5), lead
to fragmentation and depolarization of the mitochondrial network
in situ, in breast cancer cell lines and some of them also disrupted
mitochondria in BJ fibroblasts.
3.2. Effects of DMAP triterpenoid derivatives on isolated hepatic
mitochondria: evaluation of the mitochondrial oxygen
consumption
To test whether DMAP triterpenoid derivatives interfere directly
with mitochondrial function, we tested these compounds in iso-
lated rat livermitochondria, a biological model used by pharmaceu-tical companies as a reliable biosensor for drug-induced toxicity.16
To study mitochondrial respiratory parameters, both glutamate/
malate (substrates for complex I) and succinate (substrate for com-
plex II) were used formitochondrial energization in the absence and
presence of increasing concentrations (3 and 6 lg/mg of protein) of
the compounds (Fig. 3). The triterpenoid derivative compound (1)
(Fig. 3A) seemed to exert direct effects in ATP synthase Fo subunit
(for some concentrations) since the increases observed in state 2
and state 4were not visiblewhen this specific subunitwas inhibited
by oligomycin. A decrease in ADP/O ratio further confirms this re-
sult (Fig. 3A). The triterpenoid derivatives (2), (3) and (5) did not
interfere with any mitochondrial respiration parameter at the
selected concentrations (Fig. 3B, C, E), except for the RCR parameter
that was decreased in the presence of the higher concentration of
compounds (2) and (5). Compound (4), which was the most power-
ful mitochondrial respiration inhibitor, acted in the respiratory
chain in both glutamate-malate and succinate-energizedmitochon-
dria, as suggested by the decrease in FCCP-induced respiration
(Fig. 3D). Compound (4) also increased passive flux of protons
through the mitochondrial inner membrane, as shown by the in-
crease in mitochondrial respiration when ATP synthase Fo subunit
was blocked by oligomycin (state oligomycin) (Fig. 3D). State 2,
state 3 and state 4 respiratory parameters confirmed that com-
Figure 3. Effects of the triterpenoid derivatives (1–5) on mitochondrial respiratory parameters with 10 mM glutamate/5 mM malate (left panels) or 5 mM succinate (right
panels) as substrates. Mitochondria were incubated in 1 ml respiration medium (see Section 2). ADP (187.5 nmol) was added to induce state 3 respiration. Oligomycin (1 lg)
and FCCP (1 lM) were added to the system in order to inhibit passive flux through the ATP synthase and to uncouple respiration, respectively. The RCR was calculated as the
ratio between state 3 and state 4 respiration. The ADP/O ratio was calculated as the number of nmol ADP phosphorylated by n atoms of O consumed during ADP
phosphorylation. Data were expressed as % of control and represent means ± SEM of three different preparations. ⁄p <0.05 versus control. Control values for Complex I: State
2 = 19.0 ± 4.1 natoms O/min/mg protein; State 3 = 124.1 ± 20.2 natoms O/min/mg protein; State 4 = 18.0 ± 5.2 natoms O/min/mg protein; State oligomycin = 9.3 ± 2.9 natoms
O/min/mg protein; ADP/O = 2.9 ± 0.1; RCR = 9.3 ± 2.0 (mean ± SEM, n = 3). Control values for Complex II: State 2 = 22.3 ± 5.5 natoms O/min/mg protein; State 3 = 131.8 ± 8.5
natoms O/min/mg protein; State 4 = 18.3 ± 3.3 natoms O/min/mg protein; State oligomycin = 8.3 ± 2.5; natoms O/0 min/mg protein; State FCCP = 158.2 ± 25.2; ADP/
O = 2.0 ± 0.2; RCR = 6.6 ± 2.1 (means ± SEM, n = 3).
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(Fig. 3D). The values obtained for the RCR ratio of the control group
were of 9.3 ± 2.0 for complex I and 6.6 ± 2.1 for complex II, showing
that our mitochondrial preparations were well coupled, which was
further confirmed by the ADP/O ratio values of 2.9 ± 0.1 for complex
I and 2.0 ± 0.2 for complex II.
3.3. Effects of DMAP triterpenoid derivatives on isolated hepatic
mitochondria: Evaluation of the Dwm fluctuations
To investigate the effect of triterpenoid derivatives on DWm
generation, both glutamate/malate (substrates for complex I) and
succinate (substrate for complex II) were used to energize mito-
chondrial preparations. The same range of concentrations used in
mitochondrial respiratory parameters was again used (3 and
6 lg/mg of protein). Typical recordings for the effect of each one
of the tested compounds on DWm are shown in Figure 4 and quan-
titative data are presented in Supplementary Table 1. The DWm
was slightly decreased for increasing concentrations of triterpe-
noid derivative (1), when compared to the control. For the remain-
ing compounds, there was a dose-dependent immediate DWm
depolarization and an increase in lag phase, for both glutamate/
malate and succinate-energized mitochondria.
3.4. DMAP triterpenoid derivatives induce the MPT on isolated
hepatic mitochondria
MPT pore opening can be accompanied by an increase in mito-
chondrial internal volume (mitochondrial swelling) and by a de-
crease in DWm. The two phenomena can be followed
experimentally by measuring the changes in the suspension absor-
bance at 540 nm and by using a TPP+ selective electrode, respec-
tively. In the present work, MPT pore opening was induced by
Ca2+ in a phosphate-buffer medium and measured in the absence
and in the presence of the DMAP triterpenoid derivatives. Fig. 5
shows typical recordings of the effect of the tested compounds
on calcium-induced MPT pore opening followed by measuring
DWm fluctuations. Increasing concentrations of compounds (3)
and (5) caused calcium-induced DWm dissipation, but compounds
(1), (2) and (4) had the more pronounced effects. An additional
control with FCCP was performed in order to investigate if the
MPT pore induction could be due to the small decrease in DWm,
caused by the compounds. The results show that the MPT-inducing
effect of the test compounds was not caused by a depolarizing ef-
fect. Similarly to what happened in DWm experiments, mitochon-
drial swelling was most drastically observed for increasing
concentrations of compounds (1), (2) and (4), with compounds
(3) and (5) having a milder effect (Fig. 6). Both approaches demon-
strated that the effect of the tested compounds in MPT pore induc-
tion was dose-dependent. The MPT pore desensitizer,17 CsA,
prevented both mitochondrial swelling (Fig. 6) and DWm dissipa-
tion (Fig. 5), confirming the involvement of MPT pore induction.
3.5. DMAP compounds do not cause osmotic swelling of
mitochondria
The osmotic swelling assay in non-energized rat liver mito-
chondria in the presence of different ionophores is a standard
experimental protocol to study.18 To investigate the capacity of
DMAP triterpenoids to trigger mitochondrial swelling as a result
of an increased permeability of the inner membrane to ions, differ-
ent isosmotic reaction media were used with non-respiring mito-
chondria (Fig. 7). The effect of DMAP triterpenoids on proton
permeability was examined using a NH4NO3 based medium. In this
case (Fig. 7A), nitrate is freely permeable, while ammonia crosses
the membrane in the unprotonated form (NH3). The net result ofthe influx of NO3 and NH3 is that electroneutrality (and swelling)
can only be achieved by the influx of protons. In these experiments,
the control FCCP caused the largest increase in mitochondrial
swelling, as opposed to DMAP compounds, which did not cause
any increase in proton permeability. Moreover, in contrast to the
ionophore valinomycin, DMAP compounds did not promote elec-
trochemical equilibrium, as determined by mitochondrial swelling
due to the influx of potassium and thiocyanate in an isosmotic
medium containing KSCN (Fig. 7B). Finally, the effect of DMAP trit-
erpenoids was tested in mitochondria incubated in an isosmotic
KCH3COO medium (Fig. 7C). Acetate, in its neutral protonated
form, crosses the mitochondrial inner membrane.18 The membrane
impermeability to potassium was overcome with valinomycin.
Mitochondrial swelling, indicative of influx of both acetate and
potassium, was only achieved when FCCP was added to promote
the efflux of protons and maintain the electroneutrality of the sys-
tem. The compounds did not cause any noticeable effect on proton
permeability.
4. Discussion
The increased resistance to apoptosis induction is a common
feature in many cancers. Since mitochondria occupy a strategic po-
sition between bioenergetic/biosynthetic metabolism and cell
death regulation, these organelles emerged as idealized targets
for cancer therapy.19 Thus, compounds that directly affect mito-
chondrial function and trigger apoptosis are considered as poten-
tial anti-cancer agents. Triterpenoids are a class of natural
occurring compounds with ubiquitous distribution, and whose
anticancer activity was previously documented and observed to
be dependent on apoptosis induction via direct mitochondrial
alterations.3 Betulinic acid is one of such natural compounds that
display a notable level of discrimination in promoting apoptosis
in some cancer cell lines such as melanoma,8 glioma and ovarian
carcinoma.5 Although extracted from natural sources in large
amounts, the use of these triterpenoids in the same form as exist-
ing in nature remains quite limited due to their low solubility, high
pH in solution and high molecular weight.9 The design of new syn-
thetic derivatives of these compounds, taking advantage of quanti-
tative structure–activity relationships (QSARs), could help
producing more active and selective compounds to overcome these
limitations. With this in mind, DMAP derivatives of lupane triterp-
enoids were synthesized based on birch bark lupane triterpenoids
betulin and betulinic acid.9 Our research group has previously
tested a number of DMAP derivatives on human melanoma cell
lines.5 These novel compounds induced mitochondrial fragmenta-
tion and depolarization, along with an inhibition of cell prolifera-
tion.5 The potency of their effects was correlated with the
number, position, and orientation of the DMAP groups. Overall,
the extent of proliferation inhibition mirrored the effectiveness
of mitochondrial disruption.5 The present work is a follow-up to
this previous study, aiming at understanding in more detail the
mechanisms behind the mitochondrial toxicity observed.5 We have
selected a panel of 5 different compounds from the original tested
in order to be representative of the strength of mitochondrial ef-
fects. DMAP derivatives (2) and (5) were catalogues as weak mito-
chondrial perturbants, whereas compounds (1) and (3) were
considered of intermediate strength. Finally, compound (4) was
considered by Holy et al. as a strong mitochondrial perturbant.5
All the DMAP triterpenoid derivatives in this study have a
hydrophobic central region composed by four cyclohexane rings
and one cyclopentane ring which corresponds to betulinic acid
(Fig. 1). Polar groups were added to the structure backbone in or-
der to provide an increased amphiphilic character to molecules.
This ring-like structure gives a planar geometry to molecules and
provides affinity to hydrocarbon-chain of fatty acids of phospholip-
Figure 4. Representative recordings of the effect of all triterpenoid derivatives on DWm. Hepatic mitochondria (1 mg) were incubated in 1 ml of standard reaction medium as
described in Section 2. Mitochondria were energized by adding 5 mM glutamate/2.5 mMmalate (A) or 5 mM succinate with 3 lM rotenone. (B) ADP (125 nmol) was added to
initiate state 3 and valinomycin (Val.) 0.2 lg was added to the system in order to confirm if triterpenoid compounds interfere with the TPP+ electrode. DMAP compounds
3 lg/mg protein and 6 lg/mg protein were pre-incubated with 1 mg of protein for 1 min prior the ADP addition. Quantitative data are presented in Supplementary Table 1.
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means that the compounds are likely to be positively charged in
the physiological environment and preferentially interact with an-
ionic membrane lipids. Once inserted in plasma membrane the ori-
entation and localization of DMAP groups promotes their rapid
diffusion towards the cytosol. It is expected that once in cytosol,
the DMAP derivatives translocate to mitochondria driven by the
negative charge in the matrix.
In our previous study, we reported mitochondrial structure and
function alterations in the presence of these triterpenoid deriva-tives in melanoma cells.5 In the present study, we used epifluores-
cence microscopy to investigate in situ mitochondrial effects in the
breast cancer cell lines MCF7 (estrogen-sensitive) and Hs 578T
(estrogen-insensitive), compared to a non-tumoral cell line. This
allowed confirming that the previous observations were not cell/
tumor-type specific. The fluorescent probe MitoTracker Red was
used not only to detect alterations in mitochondrial membrane
polarization but also to give insights into the morphology of the
polarized network. Compound (5) did not present any significant
effect on mitochondrial morphology or polarization (Fig. 2),
Figure 5. Representative recording of the effect of increasing concentrations of triterpenoid derivatives on calcium-induced MPT pore indirectly followed by measuring DWm
fluctuations, using a TPP+ selective electrode (see Section 2). Mitochondria were incubated in 1 ml of reaction medium and energized by succinate (5 mM). Triterpenoid
derivatives at various concentrations were incubated for 2 min with mitochondria. Calcium (30–60 nmol, depending on the mitochondrial preparation) was added to the
system in order to induce MPT pore. Control with FCCP was performed in order to verify if MPT pore was induced due to the decrease of DWm. Control with CsA was carried
out for compound (1) in order to prevent mitochondrial depolarization resulting from MPT pore induction. CsA was pre-incubated with mitochondrial suspension before the
addition of the compound and calcium. Calcium additions are represented by grey arrows.
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of mitochondrial function, in all cell lines (Fig. 2). Compound (1)
induced fragmentation and depolarization of the mitochondrial
network in the two cancer cell lines (Fig. 2).
Since mitochondrial structure and function was compromised
in breast cancer, and also in melanoma cell lines5 after incubation
with the triterpenoid derivatives, we investigated whether the
compounds exerted direct effects on isolated rat hepatic mitochon-
dria, in order to gain more mechanistic insights into their effects.
Although normal hepatic and cancer cell mitochondria present
some structural and functional differences,20 we believe that suffi-
cient similarities exist to justify the use of isolated hepatic
mitochondria as models to study the interactions of tested com-
pounds with mitochondria. Isolated mitochondrial fractions have
been previously used as a biological model by pharmaceutical
companies as a sensitive and reliable biosensor for drug-induced
toxicity.16
Our results show that compound (1) appeared to have an effect
in the phosphorylative system, as suggested by the decrease in the
ADP/O ratio (Fig. 3A). Compounds (5), (3) and (2) did not elicit any
alteration in respiratory parameters, with the exception of a RCR
decrease observed for compounds (5) and (3) (Fig. 3E, C, B). The re-
sults also suggest that some of the compounds studied may pres-
ent mixed effects including inhibition of the respiratory chain
and uncoupling, the latter being suggested, for example, by the
immediate depolarization observed upon addition of the com-
pounds to the mitochondrial suspension (Fig. 4). Compound (4) in-duced multiple levels of mitochondrial toxicity, appearing to have
a protonophoretic/uncoupler effect and at the same time to inhibit
the respiratory chain, as seen by a decrease in FCCP-induced max-
imal respiration. Both effects may have contributed to the increase
in phosphorylative lag phase and to the reduction in the ADP/O ra-
tio (Fig. 3D). The increase in the lag phase observed in the presence
of some of the compounds can be partly explained by DWm depo-
larization induced by the compound itself, due to its positive
charge. However, the depolarization induced by compound (4)
can also be linked to a direct effect on the respiratory chain, as well
as to increased permeabilization to protons (Fig. 3D).
Two distinct experiments (mitochondrial swelling and DWm
fluctuations) demonstrated that increasing concentrations of com-
pounds (1), (2) and (4) induced the MPT pore (Fig. 6). The results
obtained for compounds (1) and (2) are very interesting, since both
compounds induced the MPT pore at concentrations that did not
present marked toxic effects on mitochondrial respiration
(Fig. 3A and B). The maintenance of mitochondrial integrity is ex-
tremely important because apoptosis is an ATP-dependent pro-
cess.21 With these results, it is predictable that DMAP derivatives
(1) and (2) may induce cell death through a MPT pore-related
mechanism. This phenomenon is considered very important, not
only in the crossroad between apoptosis and necrosis, but also in
organ dysfunction associated with different pathologies.22 Con-
firming cell experiments and mitochondrial oxygen consumption,
compound (5) did not present any effect in MPT pore for the con-
centrations and time points tested (Fig. 7). Together, these results
Figure 6. Typical recordings of the effect of increasing concentrations of triterpenoid derivatives on calcium-induced MPT pore followed by measuring variations in
mitochondrial volume and evaluated by the decrease in optical density at 540 nm. (A) Hepatic mitochondria (1 mg) were suspended in 2 ml of swelling medium and
energized by succinate (5 mM) as described in Section 2. Triterpenoid derivatives at various concentrations were allowed to incubate with mitochondria. Calcium (70–
100 nmol, depending on the mitochondrial preparation) was added to the system in order to induce MPT pore. For each assay, a negative control with CsA was performed in
order to prevent mitochondrial swelling. CsA was pre-incubated with mitochondrial suspension before the addition of tested compounds (at maximum concentrations) and
calcium. (B) Quantitative effects of triterpenoid derivatives on Ca2+-induced mitochondrial swelling evaluated by the decrease of optical density at 540 nm. The values
represent swelling rates, measured two minutes after calcium addition. Data are means ± SEM of three to four independent preparations. ⁄p <0.05 versus control. Values are
expressed as % to the control, an assay in which energized mitochondria were added the same amount of calcium, but in the absence of any of the tested compounds,
represented in the legend as 0 lg/mg protein. Note that in the presence of CsA, the swelling rate was much smaller than the one found for the control assay.
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the toxicity of these agents. Although compound (3) induced depo-
larization and fragmentation of the mitochondrial network in can-
cer cell lines (Fig. 2), this compound showed a very small degree of
toxicity on mitochondrial respiratory parameters (Fig. 4C) and had
a marginal effect, if any, in the induction of the MPT pore, at least
when evaluating mitochondrial swelling (Fig. 6) for the concentra-
tions tested, which suggests that compound (3) may exert its
activity on cancer cells independently of direct mitochondrial ef-
fects. The fact that mitochondrial depolarization occurs with the
addition of compound (3) (Fig. 5), implies that the compound is
accumulated by mitochondria but no toxicity results from that.Another relevant observation is that mitochondrial depolariza-
tion was visible after 48 h of treatment in cancer cells whereas in
isolated mitochondrial fractions, a depolarizing effect, either
resulting from the addition of the compound itself, or from other
effects on the respiratory chain or on the MPT itself, was visible
after some seconds/minutes. This may result from the fact that
barriers to mitochondria/compound interaction are present in
the intact cell. Several factors, including compound binding to
media serum and passage and/or passive binding to plasma/orga-
nelle membranes, may lead to a delay in the accumulation of crit-
ical compound concentrations in mitochondria. Also, for our own
experience, measurement of mitochondrial DWm based on epiflu-
Figure 7. Assessment of ion transport across mitochondrial membranes as a cause of mitochondrial swelling. Passive proton permeability of the inner membrane in the
presence (6 lg/mg prot) or absence of the tested triterpenoid (excluding compound (5)) was estimated as swelling of non-respiring/non-energizing mitochondria in
isosmotic medium with (A) NH4NO3, (B) KSCN and (C) KCH3COO. FCCP (1 mM) or valinomycin (1 mg) were used to maximally increase the permeability to protons and to
potassium, respectively. Mitochondrial swelling was assessed by changes in optical density measured at 540 nm. Data are means ± SEM of four independent preparations. ⁄p
<0.05 versus control.
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Tracker Red in intact cells is not as sensitive as measuring the
same parameter with a TPP+ electrode in isolated mitochondrial
fractions, in which a small depolarization of 5–10 mV can be
measured.
An interesting result came from osmotic swelling experiments
where none of the compounds appeared to increase the inner
mitochondrial membrane permeability to potassium or protons
(Fig. 7). Although the latter result disagrees with the hypothetical
protonophoretic activity that we proposed to explain part of the
depolarizing effects of the compounds, there may be a simple
explanation for this. Since osmotic experiments are made with
non-energized mitochondria, there is no driving force for the
charge-driven accumulation of compounds in mitochondrial mem-
branes, thus greatly limiting their effect.
We can also speculate that the activity of DMAP triterpenoid
derivatives may depend on the DMAP group position. Although
compounds (1) and (3) are theoretically similar (Fig. 1) having
the same number of positive charges at physiological pH and dif-fering only in the DMAP position groups, their effects are notably
distinct. As expected for compound (5), the lower affinity to lipid
membranes and low positive net charge5 was reflected by the ab-
sence of activity in the models tested, which confirms that promis-
ing compounds must have an amphiphilic character and be
positively charged to exert their biological activity on organelles
with the highest negative potential inside, such as mitochondria.
The present work also serves as a framework for the development
of derivatives able to distinguish cancer from non-cancer cells
based on their native mitochondrial DWm.5. Conclusion
In general, the present work corroborates the idea that DMAP
triterpenoid derivatives are promising in cancer therapy. The
experiments with isolated mitochondria demonstrate that some
of these agents can directly induce MPT pore in concentrations that
did not interfere with normal mitochondrial metabolism, suggest-
T. C. Bernardo et al. / Bioorg. Med. Chem. 21 (2013) 7239–7249 7249ing that this may be a valid mechanism that explains their toxicity.
Global analysis of the results show that, despite a single exception,
toxicity on isolated mitochondrial fractions correlates well with
in situ cell mitochondrial toxicity. Further assays are clearly
needed to explore the mechanisms of mitochondrial toxicity of
the test compounds in more detail, since the borderline between
a desired pharmacological effect (i.e., disruption of mitochondrial
function in cancer cells) and a toxic side-effect (mitochondrial tox-
icity in non-target organs) is often very blurry.
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